6-Methoxyethylamino-numonafide (MEAN) inhibits hepatocellular carcinoma as a single agent or in combination with sorafenib
Liu, Yanning2; Lou, Guohua2; Norton, John3; Wang, Chen3; Kandela, Irawati4; Tang, Shuai1; Huang, Min1; Avram, Michael3; Green, Richard3; Mazar, Andrew4
2015-08-01
卷号75
DOI10.1158/1538-7445.AM2015-1752
会议录CANCER RESEARCH
会议录出版者AMER ASSOC CANCER RESEARCH
文献子类Meeting Abstract
语种英语
WOS研究方向Oncology
WOS记录号WOS:000371578503237
内容类型会议论文
源URL[http://119.78.100.183/handle/2S10ELR8/266125]  
专题药理学第一研究室
中科院受体结构与功能重点实验室
新药研究国家重点实验室
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China;
2.Zhejiang Univ, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China;
3.Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA;
4.Northwestern Univ, Chicago, IL 60611 USA;
5.NIDDK, NIH, Bethesda, MD 20892 USA
推荐引用方式
GB/T 7714
Liu, Yanning,Lou, Guohua,Norton, John,et al. 6-Methoxyethylamino-numonafide (MEAN) inhibits hepatocellular carcinoma as a single agent or in combination with sorafenib[C]. 见:.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace